About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, November 15th, 2013

The QualityStocks
Daily Stock List


Sitoa Global, Inc. (STOA)

Pennybuster, Penny Stocks24, Bird Gang Stocks, Stock Analyzer, and ThePUMPTracker reported earlier on Sitoa Global, Inc. (STOA), and we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Sitoa Global, Inc. specializes in providing e-commerce solutions and services that allow multi-channel B2C (Business-to-Consumer) and B2B (Business-to-Business) transactions. The Company’s solutions and services enable e-commerce transactions with speed and efficiency. In addition, they allow an interactive and engaging customer experience and targeted marketing and advertising. Sitoa Global lists on the OTC Markets’ OTCQB, and the Company has their corporate headquarters in Wan Chai, Hong Kong,

Sitoa works to make possible new advances in e-commerce via building and managing leading online marketplaces that match online sellers with targeted customer groups. They provide a user-friendly and complete platform, the "Focused Social Marketplace." This platform empowers online retailers to employ a social marketplace e-commerce site. Their platform allows building marketplaces for online sellers with focused social customer networks to increase their sales channels without the risks of focus dilution, and increased capital and operating costs.  Sitoa Global's revenues come from one-time integration fees for the implementation of e-commerce solutions, as well as recurring license and service fees.

Currently, Sitoa Global hosts several existing e-commerce solutions. These include 4-GS, Ltd., which is a B2B e-commerce platform; and ZBL Cybermarketing, Ltd., which is a Search Engine Marketing (SEM) and Search Engine Optimization (SEO) provider in Northern China. ZBL Cybermarketing employs Sitoa Global’s e-commerce solutions to identify and engage targeted consumer segments and optimize purchase conversions. Furthermore, Sitoa Global’s e-commerce solutions include iMedia, Ltd., which is a mobile advertising platform.

The Company’s e-commerce solutions include a B2B e-commerce platform that optimizes supply chain sourcing for global enterprise customers by way of B2B search engine optimization (SEO), e-catalog, and inventory management systems, and a transaction platform. Their solutions also include a mobile advertising platform that allows online vendors to reach and engage their customer audience via mobile advertisements and applications.

Sitoa’s e-commerce solutions also consist of a bi-lingual e-commerce site in China. This site focuses on consumer and corporate online customers looking to buy U.S. specialty products and Chinese gift items. Moreover, the Company’s solutions include a destination e-commerce site to purchase retail clothing products for women of sizes 12 and above.

Sitoa Global, Inc. (STOA), closed Friday’s trading session at $0.0003, even for the day, on 27,978,873 volume with 28 trades. The average volume for the last 60 days is 27,643,026 and the stock's 52-week low/high is $0.0002/$0.065.

Nevada Gold Corp. (NVGC)

Obscure Stocks, SmallCapVoice, Pumps and Dumps, PennyStocks24, Penny stock Profitz, wallstreetpennystockadvisors, and Stock Castle reported this week on Nevada Gold Corp. (NVGC), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Bulletin Board, Nevada Gold Corp. is an exploration company concentrating on precious metals targets in the gold rich area of North Eastern Nevada.  The Company has optioned a 2,400 acre exploration target in Northern Nevada's Long Canyon Trend. The Company was formerly known as Massey Exploration Corp. They changed their corporate name to Nevada Gold Corp. in July of 2012. Nevada Gold is based in Del Mar, California.

Pertaining to the Long Canyon Trend, in August 2012, Nevada Gold entered into an option agreement to acquire 120 claims. The four sections consist of approximately 2,560 acres. The private lease holder also optioned to Nevada Gold another contiguous four sections of 120 claims in the same location. Nevada Gold’s claim blocks are in the Spruce Mountain area of southern Elko County.

Nevada Gold entered into a formal option agreement to acquire up to a 75 percent interest in a former producing high grade silver, lead, gold mine located in the State of Nevada. The Diamond Jim Mine in Elko County consists of 35 claims. It is in northeastern Nevada, 20 miles south of the Idaho border, 69 miles north of Elko, and 260 miles northeast of Reno. This property encompasses a section of the historic Island Mountain mining district which was first prospected in the 1860's.

The Diamond Jim Mine lies near the northern flank of the Midas Trough metallogenic trend. This trend is host to several large and world-class deposits. These include the Midas-Ken Synder and Jerritt Canyon mines. Epithermal vein systems and “Carlin Type” sedimentary-hosted deposits are found within the Midas Trough. The Company’s plan is to conduct an initial surface exploration program and seek a permit to reopen the old mine workings to verify pervious exploration results.

Yesterday, Nevada Gold President Merrill Moses reported that the Company is sending a three-man crew to the Diamond Jim Mine, starting the week of November 18, 2013. This initial phase one program will include some limited surface chip and geochemical sampling, and the inspection of the openings of the mine shafts. The crew will also locate and gather samples from the tailings dumps positioned at the Diamond Jim Mine - if weather permits. This phase one exploration program will assist Nevada Gold in planning a more in-depth phase two exploration program scheduled for next year.

Nevada Gold Corp. (NVGC), closed at $0.335, up 1.52%, on 2,345,695 volume with 528 trades. The average volume for the last 60 days is 362,603 and the stock's 52-week low/high is $0.0601/$3.74.

Advanced Medical Isotope Corp. (ADMD)

SmallCapVoice reported yesterday on Advanced Medical Isotope Corp. (ADMD), PennyStocks24, AMIStockReports, Penny Stock Buzz did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Kennewick, Washington-headquartered Advanced Medical Isotope Corp. involves in the production and distribution of medical isotopes. Medical isotopes (radioisotopes) are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage, and treat diseases.  The Company is developing medical isotope technologies, which are changing the practice of medicine and transforming the standard of medical care. Their team consists of radio-chemists, scientists, and engineers. They collaborate with national labs and universities to implement proprietary technologies capable of producing vital medical isotopes on U.S. soil.

Advanced Medical Isotope’s goal is to empower physicians, medical researchers, and ultimately, patients, through providing them with essential medical isotopes to detect, manage, and cure human disease, and improve the lives of patients.

Advanced Medical Isotope employs creative production methods to offer a wide assortment of reliable, domestically produced medical isotopes and in vivo delivery systems. The specific isotopes required are in short supply and must be created. The most common radioisotope used in diagnosis is technetium-99, with approximately 30 million procedures each year. This accounts for 80 percent of all nuclear medicine procedures around the world.

Advanced Medical Isotope employs a proton linear accelerator (PULSAR®) manufactured by AccSys Technology, Inc., a Hitachi Company. The Company has targeted this compact isotope production system as their initial differentiated technology. Their medical isotope products include stable isotopes, radio pharmaceuticals, as well as radio chemicals. Future isotopes include Indium-111; Iodine-124; Strontium-82/Rubidium-82 generators; Germanium-68/Gallium-68 generators, and Actinium-225/Bismuth-213 generators.

In early November, Advanced Medical Isotope announced that they filed pre-market notification to the Food and Drug Administration (FDA) pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for the Company’s Yttrium-90 RadioGel™ patented brachytherapy cancer product. The Company’s intention is to file FDA pre-market notifications for two related Yttrium-90 "Y-90" brachytherapy products punctually after receiving either clearance from the FDA for the Y-90 RadioGel™ device, or any comments from the FDA to their application.

Advanced Medical Isotope Corp. (ADMD), closed Friday’s trading at $0.108, down 10.00%, on 708,895 volume with 94 trades. The average volume for the last 60 days is 240,186 and the stock's 52-week low/high is $0.0301/$0.28.

Intrusion, Inc. (INTZ)

PennyOmega and OTC Picks reported previously on Intrusion, Inc. (INTZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Intrusion, Inc. is a worldwide provider of entity identification systems, advanced persistent threat identification, high speed data mining, regulated information compliance, data leak prevention and data privacy protection, and network intrusion prevention and detection products. The Company’s products help protect critical information assets by rapidly detecting, protecting, analyzing, and reporting attacks or misuse of classified, private, as well as regulated information for government and enterprise networks. Intrusion has their headquarters in Richardson, Texas. The Company’s shares trade on the OTCQB.

Intrusion's product families include TraceCop™ for entity identification. TraceCop™ is a suite of Internet monitoring and tracking products, which provide unique capabilities around the identification of malicious and illegal activities based on historical and current Internet usage data.

The Company’s product families also include Savant™ for advanced persistent threats and network data mining. Savant™ is a transparent network data capture and analysis solution. It brings science into corporate decision making based on indisputable, quantifiable data for potential issues. Furthermore, Intrusion’s product families include Compliance Commander™ for regulated information compliance, data leak prevention and data privacy protection, and Intrusion SecureNet for network intrusion prevention and detection. 

This week, Intrusion announced financial results for the three and nine months ended September 30, 2013. The Company’s Net Income was $173,000 in the third quarter of 2013 versus $48,000 in the third quarter of 2012. Their Revenue for the third quarter of 2013 was $2.0 million in comparison to $1.9 million in the third quarter of the prior year. Gross Profit was $1.2 million or 60 percent of revenue in the third quarter of 2013 versus $1.1 million or 58 percent of revenue in the third quarter of the prior year.

G. Ward Paxton, President and Chief Executive Officer of Intrusion, stated, "During the third quarter of 2012, we booked a total of $3.7 million of orders covering 10 different projects. Included in the orders was $0.2 million of our new Savant product.  Revenue for the new product was $0.4 million in the quarter.  Bookings of new orders in the 4th quarter have already reached $0.9 million with $0.5 million coming from our new Savant product.  Savant is focused in the newest security area, Advanced Persistent Threats (APT)."

Intrusion, Inc. (INTZ), closed Friday at $1.41, up 8.46%, on 69,211 volume with 32 trades. The average volume for the last 60 days is 6,151 and the stock's 52-week low/high is $0.0802/$1.30.

Nutranomics, Inc. (NNRX)

PennyStocks Forever, Pumps and Dumps, Stock Stars, MonsterStocksPicks, PennyStocks24, PennyOmega, Real Pennies, and Global Equity Alert reported on Nutranomics, Inc. (NNRX), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Based in Draper, Utah, Nutranomics, Inc. engages in the research and development of nutritional food products. They produced and branded their own product line in 1997, and began to sell to retail outlets and to the public. The Company’s corporate mission is to increase human health and longevity through education and self-awareness.  Additionally, Nutranomics has produced formulas for hundreds of other companies. 

The Company’s supplements are top-quality food and plant based products. They are blended from the highest quality sources available. In addition, they have high bioavailability. Nutranomics uses 100 percent plant cellulose (hypromellose) vegetarian capsules. These capsules are free of SLS and animal tissue. The Company does not dilute their supplements with fillers, flow agents, binders, or other additives.

Nutranomics only uses clinically studied raw materials in the products they sell. The Company goes through an extensive testing process with each batch they receive to ensure their purity, potency, as well as quality. The bioavailability and digestion of the vitamins and minerals is further enhanced by Nutranomics’ patented AES® (Assimilation Enhancing System®). This is a blend of plant based digestive enzymes and mineral cofactors that are needed for proper assimilation of food nutrients.

Yesterday, the Company announced that they acquired the exclusive North American sales and distribution rights to the Nutriband delivery system. This is a unique and commercialized health supplement transdermal patch system presently available in Europe. The design of Nutriband transdermal patches are on the principle that many nutrients can be absorbed not only orally, but also via the skin.

Today, Nutranomics announced that their intention is to launch a number of newly developed Nutranomics branded products in the developing multi-billion dollar cosmoceutical and anti-aging industry. The first Nutranomics branded product expected to be released from the potential new cosmoceutical and anti-aging line is the "Collagen Enhancer". This is a nutraceutical food supplement product. The design of it is to assist the body in the creation of collagen. The Company anticipates launching the new 120ml ready-to-drink liquid formula in Asian and North American markets in January 2014.

Nutranomics, Inc. (NNRX), closed Friday’s trading session at $0.635, up 4.96%, on 643,856 volume with 296 trades. The average volume for the last 60 days is 1,087,166 and the stock's 52-week low/high is $0.12/$1.48.

Lion Biotechnologies, Inc. (LBIO)

Today we are reporting on Lion Biotechnologies, Inc. (LBIO), here at the QualityStocks Daily Newsletter.

Lion Biotechnologies, Inc. (previously Genesis Biopharma, Inc.) engages in the development of T-cells and engineered T-cells for the treatment of various cancers. Their lead product candidate is a ready-to-infuse autologous T-cell therapy utilizing tumor-infiltrating lymphocytes (TILs) for the treatment of patients with Stage IV metastatic melanoma. The basis of this product is on a clinical CRADA with the National Cancer Institute (NCI) along with physician-sponsored investigational therapy at the MD Anderson Cancer Center and the H. Lee Moffitt Cancer & Research Institute. Headquartered in Woodland Hills, California, the Company changed their name to Lion Biotechnologies, Inc. this past September.

At the end of September, Lion Biotechnologies provided updated results from a Phase II trial for metastatic melanoma conducted by the National Cancer Institute (NCI) utilizing the tumor-infiltrating lymphocyte (TIL) technology presently licensed by Lion Biotechnologies and undergoing development under a Cooperative Research and Development Agreement (CRADA) with the NCI. Steven A. Rosenberg, M.D., Ph.D., Chief of the NCI Surgery Branch, is the Principal Investigator on this study. The single-site trial included 93 patients in three cohorts. Overall, patients in the three cohorts showed a 22 percent Complete Response (CR). In addition, 95 percent of those patients continue to live with no measurable disease 6-to-9 years following treatment.

Lion Biotechnologies announced last week that the Company completed a previously announced private financing with institutional and other accredited investors for gross proceeds of $23.3 million. They received net proceeds of approximately $21.6 million after paying the placement agent fees and estimated offering expenses payable by the Company. At the closing, Lion Biotechnologies issued 3,145,300 shares of common stock, 17,000 shares of their new Series A Convertible Preferred Stock, and warrants to purchase 11,645,300 shares of Common Stock.

Manish Singh, Ph.D., President and Chief Executive Officer of Lion Biotechnologies, said, “We are very pleased to have raised the capital we believe is required to take our lead T-cell program into a Phase III clinical study for metastatic melanoma as well as sponsor several additional combination studies of check point inhibitors and T-cells. The quality of the investors participating in this financing is a strong endorsement of our clinical results to-date and of the potential for tumor-infiltrating lymphocyte technology.”

Lion Biotechnologies, Inc. (LBIO), closed Friday’s session at $5.35, up 22.99%, on 102,248 volume with 115 trades. The average volume for the last 60 days is 2,535 and the stock's 52-week low/high is $3.18/$18.00.

Titan Pharmaceuticals, Inc. (TTNP)

OTC Stock Review, Stock Analyzer, MonsterStocksPicks, Stock Stars, Stock Analyzer, PennyStocks24, SmallCap Network, Wealthpire Inc., The Street, OTCJournal, and Real Pennies reported earlier on Titan Pharmaceuticals, Inc. (TTNP), and we report on the Company, here at the QualityStocks Daily Newsletter.

List on the OTC Bulletin Board, Titan Pharmaceuticals, Inc. is a biopharmaceutical entity headquartered in South San Francisco, California. The Company is developing proprietary therapeutics principally for the treatment of central nervous system (CNS) disorders. Their main asset is Probuphine®. This product is the first slow-release implant formulation of buprenorphine hydrochloride (buprenorphine). Probuphine® is the first product to utilize ProNeura™ - a novel, proprietary, long-term drug delivery technology.

The ProNeura™ technology has the potential to be used in developing products for the treatment of other chronic conditions, including Parkinson's disease. The design of Probuphine® is to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. A seven-day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in 2011 in the U.S.

The Probuphine New Drug Application (NDA) underwent submission to the U.S. Food and Drug Administration (FDA) in October of 2012 seeking approval for the treatment of opioid dependence. The goal of Titan Pharmaceuticals is to enter into one or more collaborations with capable pharmaceutical companies to commercialize Probuphine® in the U.S. and worldwide markets, and to develop, potentially, the product for the treatment of chronic pain.

In addition, the Company is entitled to royalty revenue of 8-10 percent of net sales of Fanapt® (iloperidone). This is an atypical antipsychotic compound being marketed in the United States for the treatment of schizophrenia by Novartis Pharma AG under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension).

Titan Pharmaceuticals announced this past September that the FDA granted the Company’s request for a meeting to discuss Probuphine. The goal of this meeting is to understand more completely the issues raised in the April 2013 Complete Response Letter (CRL) to the NDA for Probuphine for the maintenance treatment of opioid dependence in adults, review and discuss the available data from the Probuphine studies conducted to date, and gain additional clarity regarding the regulatory path forward for Probuphine. Complete briefing materials addressing the issues raised in the CRL were submitted to the FDA; the meeting is scheduled for November 19, 2013.

This week, Titan announced a $5 million equity investment by Braeburn Pharmaceuticals Sprl and a restructuring of certain terms of the License Agreement for commercialization of Probuphine®, chiefly to adjust the timing and amount of the approval and sales milestones. The agreements reflect Titan Pharmaceuticals’ need to address their cash flow requirements through next year given the generally uncertain nature of the regulatory process concerning timing and outcome. Additionally, the agreements address Braeburn's recognition of the potential impact of the delay in the regulatory approval process, and the changing market for opioid addiction treatments, on their investment in Probuphine and enable Braeburn to continue advancing the regulatory process and support the commercialization of Probuphine, if approved.

Titan Pharmaceuticals, Inc. (TTNP), closed Friday’s trading session at $0.81, up 1.89%, on 256,206 volume with 149 trades. The average volume for the last 60 days is 615,163 and the stock's 52-week low/high is $0.32/$2.53.

BeesFree, Inc. (BEES)

Real Pennies reported yesterday on Treaty Energy Corp. (TECO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

In the development stage, BeesFree, Inc. focuses on developing innovative solutions for the worldwide beekeeping community. The Company owns a patent-pending composite food solution that helps honeybees avoid the effects of Colony Collapse Disorder (CCD). BeesFree is the global distributor of BeesVita Plus™. Incorporated in 2011, BeesFree has their headquarters in West Palm Beach, Florida; they also have a regional office in Argentina. The Company and their subsidiaries operate in the U.S., Argentina, and the European Union (EU). The Company’s shares trade on the OTC Markets’ OTCQB.

Colony Collapse Disorder (CCD) is the mass disappearance of honey bee colonies. Almost one-third of all honeybee colonies in the U.S. have disappeared, never to return. The latest data, from the 2012-2013 winter, indicate an average loss of 45.1 percent of hives across all U.S. beekeepers. This is up 78.2 percent from the previous winter, and a total loss of 31.1 percent of commercial hives, on par with the last six years.

BeesVita Plus™ is a patent pending, all-natural nutritional food supplement that helps honey bees avoid the effects of CCD. BeesFree has a manufacturing agreement to supply the U.S. market with BeesVita Plus™. BeesVita Plus™ is fed to honey bees year round. This product contains carbohydrates and essential amino acids. Additionally, the solution contains lipids, essential oils, minerals, as well as antioxidants. It is the only complete honey bee nutritional supplement. BeesVita Plus™ strengthens the honey bee. As a result, it enables the honey bee to withstand greater environmental toxins and stress.
In addition, the Company is developing the BeespenserTM; this is a patent pending, automated honey bee feeding system. The design of the Beespenser™ is to assist professional beekeepers in efficiently and effectively delivering BeesVita Plus™ to their colonies. The Beespenser™ provides BeesVita Plus™ for up to 50 colonies.

In September 2013, BeesFree announced that they received an order of approximately $300,000USD from a major distributor of products to several of the largest beekeepers in Argentina. The order was generated because of the earlier announced collaboration with Oleogram SA. Oleogram is an Argentine company recognized as an expert in new product and technology development in the agricultural sector.

BeesFree, Inc. (BEES), closed Friday’s trading session at $0.205, up 156.25%, on 8,500 volume with 4 trades. The average volume for the last 60 days is 5,934 and the stock's 52-week low/high is $0.007/$1.75.


The QualityStocks
Company Corner


Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.57, up 29.55%, on 3,705,276 volume with 1127 trades. The stock’s average daily volume over the past 60 days is 1,011,200, and its 52-week low/high is $0.20/$3.50.

Pan Global, Corp. reported today that it has commenced planning for further restructuring and improvements of its share capital to provide additional capitalization benefits to its shareholders. Specifically regarding one aspect of the plan, the Company is in discussions with its majority shareholder and the Company's current and potential investors for the development of a capital structure plan that the Company expects to provide long term benefits to the Company and its shareholders.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global Corp. Developing 'Capitalization Benefit Plan'

Pan Global Corp. Outlines Plans for Its Sustainable Greenhouse Business

Pan Global Corp. Shareholder Update: Pre-Closing Requirements to Acquire Small-Hydro Project on Track

Blue Water Global Group, Inc. (BLUU)

The QualityStocks Daily Newsletter would like to spotlight Blue Water Global Group, Inc. (BLUU). Today, Blue Water Global Group, Inc. closed trading at $0.0145, up 45.00%, on 417,053 volume with 9 trades. The stock’s average daily volume over the past 60 days is 54,795, and its 52-week low/high is $0.001/$0.036.

Blue Water Global Group, Inc. (BLUU) is focused on developing a chain of restaurants throughout the Caribbean region under the Blue Water Bar & Grill™ brand. In addition to its restaurant development activities, Blue Water is also engaged in making strategic equity investments in promising companies that are in the early stages of becoming publicly traded on the OTC Bulletin Board.

The Blue Water Bar & Grill™ restaurant concept features a casual Caribbean themed atmosphere designed to provide a distinctive and relaxing island dining experience. Each restaurant will have a large covered outside patio area where customers can enjoy their cuisine while overlooking a beautiful water view. The patio area will feature an inviting island styled bar and a small stage area for live musical performances by local musicians and dancing.

Expanding beyond the Blue Water Bar & Grill™ presently under development in St. Maarten, Dutch West Indies, the company aims to introduce its restaurant concept to other Caribbean islands. Management plans to open a new Blue Water Bar & Grill™ restaurant on each of the following islands in the next five years: Barbados; Aruba, Dutch West Indies; Cozumel, Mexico; Grand Cayman; and Nassau, Bahamas.

Additionally, through its strategic alliance agreement with Taurus Financial Partners, Blue Water has gained access to various financial consulting services and will be assisted with utilizing its status as a publicly traded company to conduct registered “spin-offs”. Each spin-off will be designed to reward loyal Blue Water shareholders with a dividend of the spin-off business’s stock while simultaneously enhancing Blue Water’s overall balance sheet. Disclaimer

Blue Water Global Group, Inc. Company Blog

Blue Water Global Group, Inc. News:

UPDATE - Blue Water Announces the Acquisition of a St. Maarten Business License

Blue Water Announces the Acquisition of a St. Maarten Business License

Blue Water Announces $5 Million Financing Agreement With Dutchess Capital

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.08, up 49.53%, on 388,100 volume with 6 trades. The stock’s average daily volume over the past 60 days is 33,370, and its 52-week low/high is $0.03/$0.15.

Global Payout, Inc. (GOHE) specializes in customized payment solutions for businesses and organizations worldwide. The company’s global network of banks and processing partners enable companies and organizations to efficiently deploy a customized payment solution configured specifically for each client. From solving a single payment issue to meeting an entire global payment requirement, Global Payout in conjunction with its partners delivers modular payment solutions.

Global Payout has a product line of prepaid "off the shelf" products that can be utilized or Global Payout can customize payment solutions for qualified businesses. By coupling its network of international banks and third-party processing relationships with an innovative payment platform, Global Payout enables organizations to "plug into" an efficient and cost effective method of paying employees, contractors, investors, and commissioned agents wherever they might be located in the world.

Global Payout began operations as a business to business provider of pre-paid debit cards for payroll and general spend programs. The company then launched a Prepaid Discover® card to meet the demand of its business clients in the United States. As a result of these efforts and with the input of their client base, Global Payout then greatly extended its reach by developing a new proprietary “payment platform” which enables companies and organizations to make necessary payments in every country a company does business. Clients can now make international payments without the need to establish banking relationships in each and every country they do business. Businesses now have an efficient, compliant and simplified system to make their all necessary international payments using Global Payout’s proprietary payment platform.

Global Payout delivers dependable and secure global payment solutions for companies worldwide. This relieves clients of burdensome and time consuming efforts to establish banking relationships everywhere they do business. The company’s “consolidated payment gateway” product can be configured specifically to the needs of each client within a short period of time. Global Payout is led by a management team comprised of pioneers in domestic and international payment delivery solutions. The company is well positioned to leverage their long standing international financial relationships to expand their services and global reach. Even during this expansion, Global Payout remains committed to serving domestic and international clients and providing them with customized one-stop solutions that address each client’s specific payment needs. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. CEO Featured in Exclusive QualityStocks Interview

Global Payout, Inc. Announces Engagement of QualityStocks Investor Relations Services

ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway

OBJ Enterprises, Inc. (OBJE)

The QualityStocks Daily Newsletter would like to spotlight OBJ Enterprises, Inc. (OBJE). Today, OBJ Enterprises, Inc. closed trading at $0.30, off by 3.33%, on 552,790 volume with 83 trades. The stock’s average daily volume over the past 60 days is 140,901, and its 52-week low/high is $0.25/$3.90.

OBJ Enterprises, Inc. (OBJE) utilizes a powerful joint-venture partnership model to work alongside industry experts and universities to develop educational and popular gaming applications for the digital gaming market, the fastest-growing segment of the global IT industry. The company’s operating subsidiary, Obscene Interactive, is focused on developing innovative social gaming solutions to capitalize on the burgeoning mobile app marketplace, as well as the latest advances in media distribution platforms and advertising placement within apps.

The global gaming industry is predicted to top $66 billion in 2014. As global demand for engaging new gaming content grows with advancements in technology, OBJ Enterprises is pursuing acquisitions of emerging game development companies with portfolios of progressive technology assets such as cloud computing, discrete product placement, and micro-transactions to capitalize on the explosion in console, smartphone, and tablet usage across the globe.

Leveraging innovative and proactive partners who share the company’s vision to create next-generation digital games, OBJ Enterprises has demonstrated its invaluable ability to identify both current gaming trends and keep pace with the industry’s constant evolution. The company is constantly working on new ways to capitalize on emerging gaming trends such as biometric applications - using electronic measurement of unique human characteristics such as fingerprints and irises –for medically themed games, social games, horror games, and more.

Spearheading these growth initiatives is OBJ Enterprises CEO Paul Watson, who has domestic and international experience in fundraising for startups, growth capital, business development, and venture finance. Under his leadership and backed by a team of highly experienced management, OBJ Enterprises plans to advance its gaming portfolio to include applications in health, safety, educational, corporate, and software training. Disclaimer

OBJ Enterprises, Inc. Company Blog

OBJ Enterprises, Inc. News:

Huge Market Growth Bodes Well for OBJE’s 2014 Financial Forecast

OBJE Explores Market Potential of Revolutionary Analytics Tools

OBJE Acquires Novalon Games in Preparation for Expansion

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.004, up 14.29%, on 1,850,000 volume with 13 trades. The stock’s average daily volume over the past 60 days is 2,311,866, and its 52-week low/high is $0.0025/$0.029.

Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.

The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.

Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.

SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

Singlepoint, Inc. Announces Moody Bible Institute to White Label Technology for Mobile Donations, SMS Capabilities

Singlepoint, Inc. and Linkstorm Form Strategic Alliance to Expand Singlepoint's Global Presence

Singlepoint, Inc. Announces Engagement of QualityStocks Investor Relations Services

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.13, up 3.17%, on 122,610 volume with 17 trades. The stock’s average daily volume over the past 60 days is 281,437, and its 52-week low/high is $0.041/$0.143.

CD International Enterprises, Inc. (CDII) is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas, in addition to providing business and financial consulting services. Headquartered in Deerfield Beach, Florida, with corporate offices in Shanghai, CD International Enterprises’ unique infrastructure provides a platform to expand business opportunities globally.

Through its wholly owned subsidiary, International Magnesium Group, CD International Enterprises owns and operates one of the leading producers of magnesium in the world. International Magnesium Group sources its magnesium from six production facilities in the People's Republic of China, with a combined annual production and distribution capacity of approximately 80,000 metric tons of magnesium ingots and 10,000 metric tons of magnesium powder.

CD International Enterprises also sources, aggregates, and distributes iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China via wholly owned subsidiary CDII Minerals. The scope of CDII Minerals’ services include: purchasing, financing, logistics, quality control, in addition to conducting comprehensive legal, financial, and technical due diligence on suppliers.

The company’s management team possesses the necessary leadership expertise and a solid working knowledge of the unique characteristics of business operations in the U.S., China, Mexico, and South America. Employing a global growth strategy, CD International Enterprises has the unique ability to identify emerging market opportunities and provide comprehensive solutions or services relevant to conducting cross border business. Disclaimer

CD International Enterprises, Inc. Company Blog

CD International Enterprises, Inc. News:

CD International Enterprises and Manali Engineering-India Complete Magnesium Distribution Agreement

QualityStocks Features CD International Enterprises Vice President in Exclusive Interview

CD International Subsidiary in Agreement with AEGEA, Inc. to Provide EB-5 Funding Program Consulting Services for Expansive Florida Real Estate Development Project

Sohm, Inc. (SHMN)

The QualityStocks Daily Newsletter would like to spotlight Sohm, Inc. (SHMN). Today, Sohm, Inc. closed trading at $0.0038, up 5.56%, on 102,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 291,612, and its 52-week low/high is $0.0021/$0.013.

Sohm, Inc. (SHMN) is a globally recognized pharmaceutical manufacturer that develops, manufactures, and distributes generic, private label, and Sohm-innovated pharmaceutical, cosmeceutical, and nutraceutical products. The company exports product worldwide, with a focus on distribution in emerging markets such as Africa, Latin America, and Southeast Asia.

In 2012, Sohm was voted the fastest growing generics prescription drug manufacturer at the 30th All India Conference of National Integrated Medical Association. Committed to being a global leader in improving the health and quality of people’s lives in every corner of the world, the company has U.S. headquarters in Buena Park, CA, with international headquarters located in Ahmedabad, India, and several corporate offices located within the UK and China.

Research and development activities capitalize on the company’s expertise in numerous drug delivery technologies, including solid dosage form, oral-controlled and sustained releases semi-solid, liquid, oral transmucosal, transdermal, gel, injectable, and other drug delivery technologies, as well as the application of these technologies to proprietary drug forms.

To ensure regulatory compliance, the company continuously assesses and monitors the output of the existing quality systems, and application of evolving industry guidelines and regulations. Leveraging a global presence, an expanding drug portfolio that covers all major treatment categories, and a respected brand, Sohm is well positioned to continue its rapid growth.. Disclaimer

Sohm, Inc. Company Blog

Sohm, Inc. News:

SOHM Launches SohMed(TM) Range of Branded OTC Medicines in U.S. Market

Sohm, Inc. CEO Featured in Exclusive QualityStocks Interview

SOHM, Inc. Announces Engagement of QualityStocks Investor Relations Services

Midwest Energy Emissions Corp. (MEEC)

The QualityStocks Daily Newsletter would like to spotlight Midwest Energy Emissions Corp. (MEEC). Today, Midwest Energy Emissions Corp. closed trading at $0.55, even for the day, on 30,500 volume with 10 trades. The stock’s average daily volume over the past 60 days is 10,069, and its 52-week low/high is $0.15/$1.00.

Midwest Energy Emissions Corp. (MEEC) develops and delivers patented, cost-effective mercury capture systems and technologies to power plants and other coal-burning units in the United States and Canada. As a result of the company’s innovative, patented mercury removal technologies, customers can attain compliance with new, highly restrictive government emissions regulations, in the most effective and economical manner.

In 2011, the EPA issued its Mercury and Air Toxics Standards (MATS) for power plants. The new rule is intended to reduce air emissions of heavy metals, including mercury (Hg), from all major U.S. power plants. It is projected that the total national cost of this mandate will reach $9.6 billion annually. More than a dozen states have established even more stringent emission limits, further increasing demand for energy emission control technology.

Leveraging its partnership with University of North Dakota’s Energy & Environment Research Center (EERC), the premier center of mercury control research, Midwest Energy Emissions is well positioned to meet and exceed new government regulations with its exclusive patent rights to EERC’s mercury control technology. The company’s customer-centric mercury capture solutions use a combination of materials tailored specifically to customers’ coal-fired units.

Years of research and testing with the EERC has enabled Midwest Energy to deliver one of the most effective low-cost and high-capture solutions possible – typically without impacting operations or requiring extensive capital equipment changes. The total mercury solution offered by Midwest Energy Emissions is uniquely formulated to optimize mercury capture at any coal-fired unit. Disclaimer

Midwest Energy Emissions Corp. Company Blog

Midwest Energy Emissions Corp. News:

Midwest Energy Emissions Corp. SEA™ Technology Featured in Energy-Tech Magazine

Midwest Energy Emissions Corp. to Partake as Partnering Sponsor of the Energy and Environmental Research Center Air Quality IX Conference

Midwest Energy Emissions Corp. Engagement of QualityStocks Investor Relations Services


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251